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Brain-derived neurotrophic factor (BDNF) plays an impor-
tant role in synaptic plasticity in the hippocampus, but the
mechanisms involved are not fully understood. The neuro-
trophin couples synaptic activation to changes in gene
expression underlying long term potentiation and short term
plasticity. Here we show that BDNF acutely up-regulates
GluR1, GluR2, and GluR3 -amino-3-hydroxy-5-methyl-4-
isoxazole propionic acid (AMPA) receptor subunits in 7-day
tropomyosin-related kinase in vitro cultured hippocampal
neurons. The increase in GluR1 and GluR2 protein levels in
developing cultures was impaired by K252a, a Trk inhibitor,
and by translation (emetine and anisomycin) and transcrip-
tion (-amanitine and actinomycin D) inhibitors. Accord-
ingly, BDNF increased the mRNA levels for GluR1 and GluR2
subunits. Biotinylation studies showed that stimulation with
BDNF for 30 min selectively increased the amount of GluR1
associated with the plasma membrane, and this effect was
abrogated by emetine. Under the same conditions, BDNF
induced GluR1 phosphorylation on Ser-831 through activa-
tion of protein kinase C and Ca2-calmodulin-dependent
protein kinase II. Chelation of endogenous extracellular
BDNF with TrkB-IgG selectively decreased GluR1 protein
levels in 14-day in vitro cultures of hippocampal neurons.
Moreover, BDNF promoted synaptic delivery of homomeric
GluR1 AMPA receptors in cultured organotypic slices, by a
mechanism independent of NMDA receptor activation.
Taken together, the results indicate that BDNF up-regulates
the protein levels of AMPA receptor subunits in hippocampal
neurons and induces the delivery of AMPA receptors to the
synapse.
Neurotrophins are essential for the development of the ver-
tebrate nervous system, modulate synaptic function, and play
an important role in synaptic plasticity (1, 2). Brain-derived
neurotrophic factor (BDNF)3 has been implicated in activity-
dependent synaptic plasticity, particularly in long term poten-
tiation (LTP) induced by high frequency stimulation. Accord-
ingly, LTP is impaired in the hippocampal CA1 region of
animals deficient in BDNF, but it can be rescued by supplying
the neurotrophin (3–5). Chelation of endogenous BDNF also
prevents the induction of LTP by theta burst stimulation and
reduces late phase LTP induced by high frequency stimulation
(6, 7). Furthermore, the late phase LTP induced by tetanic stim-
ulation was not observed in slices from BDNF knock-out mice
and was also abrogated when TrkB receptors were blocked (8).
Taken together, the available evidences point to a direct role of
BDNF in the early and late phases of LTP.
Binding of BDNF to TrkB receptors is followed by activa-
tion of intracellular signaling pathways, including the Ras/ex-
tracellular signal-regulated protein kinase, phospholipase C
(PLC), phosphatidylinositol-3-kinase/Akt, and Src pathways
(9–11). TrkB receptors are located on axon terminals and in the
post-synaptic density of glutamatergic synapses (12–14), but
whether the effects of BDNFon synaptic plasticity aremediated
by pre- and/or post-synaptic receptors is not fully elucidated.
BDNF was originally shown to induce a long lasting potentia-
tion of excitatory synaptic transmission in the hippocampal
CA1 region, acting at a presynaptic site (15) (for conflicting
results see Refs. 4, 6, 16–18), and subsequent studies showed
that BDNF was selectively required for those forms of LTP that
recruit a presynaptic component (19). However, activation of
post-synaptic TrkB receptors generates intracellular Ca2 con-
centration transients in dentate granule cells, which induce
LTP when paired with weak synaptic stimulation (20). The
enhancement of synaptic transmission by BDNF observed in
the dentate gyrus in vivo (21)may also be due, at least in part, to
the activation of post-synaptic receptors (22, 23). Nevertheless,
a post-synaptic role of BDNF in synaptic plasticity, and the
potential mechanisms involved, remain controversial.
The number, composition, and location of -amino-3-hy-
droxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors
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in neurons, together with receptor phosphorylation, are criti-
cally important factors in determining the neuronal response to
glutamate, and play an important role in the mechanisms of
synaptic plasticity (24). AMPA receptors are formed by the
association of GluR1-GluR4 subunits, and their delivery to the
synapse is tightly controlled by the intracellular signaling activ-
ity. In this work, we characterized the effect of BDNF on the
abundance of AMPA receptors in cultured hippocampal neu-
rons and on their cellular distribution. Furthermore, we inves-
tigated the effect of BDNF on the synaptic delivery of GluR1-
containing AMPA receptors in CA1 hippocampal neurons,
which could account for the postsynaptic effects of the neuro-
trophin in the early phase of LTP.
EXPERIMENTAL PROCEDURES
Hippocampal Cultures—Primary cultures of rat hippocam-
pal neurons were prepared from the hippocampi of E18–E19
Wistar rat embryos, after treatment with trypsin (0.06%, 15
min, and 37 °C, Invitrogen) and deoxyribonuclease I (5.36
mg/ml), in Ca2- and Mg2-free Hanks’ balanced salt solution
(5.36 mM KCl, 0.44 mM KH2PO4, 137 mM NaCl, 4.16 mM
NaHCO3, 0.34 mM Na2HPO42H2O, 5 mM glucose, 1 mM
sodium pyruvate, 10 mM HEPES, and 0.001% phenol red). The
hippocampi were then washed with Hanks’ balanced salt solu-
tion containing 10% fetal bovine serum (BioWhittaker), to stop
trypsin activity, and transferred to Neurobasal medium
(Invitrogen) supplementedwith B27 supplement (1:50 dilution,
Invitrogen), 25 M glutamate, 0.5 mM glutamine, and 0.12
mg/ml gentamycin. The cells were dissociated in this solution
and were then plated in 6-well plates (91.6  103 cells/cm2),
coatedwith poly-D-lysine (0.1mg/ml). The cultures weremain-
tained in a humidified incubator of 5% CO2/95% air, at 37 °C,
for 7 or 14 days. Cultures were stimulated with 100 ng/ml
BDNF (kind gift from Regeneron, Tarrytown, NY) for the indi-
cated periods of time.When appropriate, 200 nMK252a, 2.0M
emetine, 2.0 M anisomycin, 1.5 M -amanitine, 1.5 M acti-
nomycinD (Calbiochem), 5Mchelerythrine (Sigma), or 10M
KN-93 (Sigma) were added 30 min before stimulation, as indi-
cated. Scavenging of endogenous extracellular BDNF was per-
formedwith TrkB-IgG (1g/ml, Sigma) for 24 h. Hippocampal
slices were prepared from young rats (postnatal days 5 and 6)
and cultured on semiporous membranes as previously
described (25).
Preparation of Extracts—Hippocampal neurons were
washed twice with ice-cold phosphate-buffered saline and once
more with phosphate-buffered saline supplemented with 1 mM
dithiothreitol and a mixture of protease inhibitors (0.1 mM
phenylmethylsulfonyl fluoride, 1 g/ml chymostatin, 1 g/ml
leupeptin, 1 g/ml antipain, 1 g/ml pepstatin, Sigma-Al-
drich). The cells were then lysed with radioimmune precipita-
tion assay buffer (150 mMNaCl, 50 mM Tris-HCl, pH 7.4, 5 mM
EGTA, 1% Triton, 0.5% deoxycholic acid, and 0.1% SDS at a
final pH 7.5) supplemented with 50 mM NaF, 1.5 mM sodium
orthovanadate, and the mixture of protease inhibitors. After
centrifugation at 16,100 g for 10min, protein in the superna-
tants was quantified using the bicinchoninic acid method, and
the samples were diluted with a 2 concentrated denaturating
buffer (125 mM Tris, pH 6.8, 100 mM glycine, 4% SDS, 200 mM
dithiothreitol, 40% glycerol, 3 mM sodium orthovanadate, and
0.01% bromphenol blue).
Extracts from treated hippocampal slices were prepared in
homogenization buffer containing protease and phosphatase
inhibitors (10 mM HEPES, 500 mM NaCl, 10 mM EDTA, 10 mM
NaF, 1 M microcystin, 0.1 mM phenylmethylsulfonyl fluoride,
2 g/ml chymostatin, 2 g/ml leupeptin, 2 g/ml antipain, 2
g/ml pepstatin, 10 M sodium orthovanadate, and 1% Triton
X-100). Samples were centrifuged at 16,100 g for 4 min, and
the protein present in the supernatant was quantified using the
bicinchoninic acid method and denaturated with denaturating
buffer at 95 °C for 5 min. The proteins of interest were then
analyzed by Western blot.
Total RNA Isolation and Reverse Transcription for Real-time
PCR—Total RNA from cultured hippocampal neurons was
extracted with TRIzol reagent (Invitrogen), according to the
instructions of the manufacturer. The full content of a 6-well
cell cluster plate, with 870,000 cells/well (7 DIV), was collected
for each experimental condition. For first strand cDNA synthe-
sis, 3 g of total RNA was reverse-transcribed with avian
myeloblastosis (AMV) reverse transcriptase (Roche Applied
Science) using random primer p(dN)6 (3.2 g), dNTPs (1 mM
each), MgCl2 (25 mM), RNase inhibitor (50 units) and gelatin
(0.01g/l) in reaction buffer (10mMTris, 50mMKCl, pH 8.3)
in a total volume of 40 l. The reaction was performed at 25 °C
for 10min, followed by 60min at 42 °C, for primer annealing to
the RNA template and cDNA synthesis, respectively. The
reverse transcriptase was then denatured during 5min at 99 °C,
and the sample was cooled to 4 °C for 5min and finally stored at
80 °C until further use.
Real-time PCR—Real-Time PCR analysis of gene expression
was performed using the LightCycler System II (Roche Applied
Science). The PCR reactions were performed using LightCycler
FastStart DNA Master SYBR Green I (26) in 20-l capillaries.
The primers used for amplification of genes encoding AMPA
receptor subunits were, respectively, RGR1F2271, 5-GAA
CCA TCC GTG TTT GTT CG-3 and RGR1R2937, 5-TTC
CTG TCT GCT CCA GTT AC-3 for GluR1; RGR2F2522,
5-GAA GCC TTG TGA CAC CAT GA-3 and RGR2R3008,
5-AGC CTT GCC TTG CTC CTC AT-3 for GluR2;
RGR3F2431, 5-CAA AGG CTA TGG TGT GGC AA-3 and
RGR3R2927, 5-ACA CCA GGG AGA GTG AAA TC-3 for
GluR3; S2288, 5-TGG AGG GCG TGG CTC GTG TC-3 and
R2800, 5-TTG GGG CAG TCA GGG GTA AG-3 for GluR4.
The primers used for the amplification of endogenous control
gene 18 S rRNAwere those included in the Applied Biosystems
TaqMan Ribosomal RNA Control Reagents Kit (Porto, Portu-
gal). Each primer of a pairwas added to the reactionmixture (10
l) at a final concentration of 0.8 M with 3 mM MgCl2, in
addition to the “Hot Start” LightCycler Fast Start DNAMaster
SYBR Green I mix (1) and 1.2 l of cDNA sample. Thermal
cycling was initiated with activation of the FastStart TaqDNA
polymerase by denaturation during 10min at 95 °C followed by
45 cycles of a 30-s melting step at 95 °C, a 5-s annealing step at
58 °C, and a 25-s elongation step at 72 °C. All temperature tran-
sition rates used were at 20 °C/s. After amplification for 45
cycles, at least 10 cycles beyond the beginning of the linear
phase of amplification, samples were subjected to a melting
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curve analysis according to the instructions of the manufac-
turer to confirm the absence of unspecific amplification prod-
ucts and primer-dimers. In all experiments, samples containing
no template were included as negative controls.
mRNAQuantitative Analysis—ThemRNA levels of the con-
stitutively expressed housekeeping gene encoding 18 S riboso-
mal RNAwere used as a control, in all experiments. The relative
changes in the mRNA levels of glutamate receptor subunits in
cultured hippocampal neurons were determined using the
Cp method. Accordingly, for
each experimental condition (un-
stimulated neurons and neurons
treated with 100 ng/ml BDNF for 30
min or 3 h) the “crossing point” (Cp)
values given by the LightCycler sys-
tem II software, for each target gene,
were subtracted by the respectiveCp
value determined for the 18 S gene
from the same sample and condi-
tion (Cp). This allows normalizing
changes in target gene expression.
Afterward, theCp valueswere sub-
tracted by the respective values of
the control for the target gene giving
Cp. The derivation to the value of
2(Cp) sets each control at the
unity (or 100%), because Cp
(control) 0, and the stimuli condi-
tions used were at a percentage rel-
ative to the control.
Surface Biotinylation and Pre-
cipitation—Hippocampal cell cul-
tures were treated or not with 100
ng/mlBDNFand then incubatedwith
1 mg/ml EZ-LinkTM Sulfo-NHS-SS-
biotin (Pierce) in ice-cold phosphate-
buffered saline containing 1 mM
CaCl2 and 1 mM MgCl2, for 30 min
(27). The non-bound biotin was
removed by washing the cells with
phosphate-buffered saline containing
100 mM glycine. Cell lysates were
obtained as described above andwere
incubated with UltraLink PlusTM
immobilized streptavidin or Ultra-
Link immobilized NeutrAvidinTM
plus beads (Pierce), for 2 h at 4 °C,
under constant agitation. Non-bioti-
nylated proteins were removed by
centrifugation at 2,500 g for 3 min,
and the beads were washed three
times with radioimmune precipita-
tion assay buffer. Biotinylated pro-
teins were then eluted with denatur-
ating buffer at 95 °C for 5 min (Fig. 7,
A, C, and D) or at 65 °C for 15 min
(Fig. 7B). Samples were then pro-
cessed forWestern blotting analysis.
Western Blotting—Protein samples were separated by SDS-
PAGE, in 6% polyacrylamide gels, transferred to polyvinylidene
membranes (Bio-Rad), and immunoblotted. Blots were incu-
bated with primary antibodies (overnight at 4 °C), washed, and
exposed to alkaline phosphatase-conjugated secondary anti-
bodies (1:20,000 dilution; 1 h at room temperature). Alkaline
phosphatase activity was visualized by enhanced chemifluores-
cence (ECF) on the Storm 860 Gel and Blot Imaging System
(Amersham Biosciences) or by ECL (Fig. 9A). The following
FIGURE 1.BDNFup-regulates the protein levels of theGluR1, GluR2, andGluR3AMPA receptor subunits
indeveloping culturedhippocampalneurons.7DIV (A,C, E, and F) or 14DIV (B andD) culturedneuronswere
incubated with or without 100 ng/ml BDNF (15 min, 30 min, 1 h, 2 h, 3 h, 5 h, 6 h, 12 h, and 24 h) as indicated.
Total GluR1 (A), GluR2 (C), GluR3 (E), andGluR4 (F) protein levelsweredeterminedbyWesternblot for 7DIV, and
GluR1 (B) andGluR2 (D) protein levelsweredetermined for 14DIV. Control (0 h) protein levels ofAMPA receptor
subunitswere set to 100%.-Tubulin or-tubulinwere used as loading controls. The results are the average
S.E. of 5–9 independent experiments, performed in independent preparations. Statistical analysis was per-
formed by one-way ANOVA, followed by the Dunnett test. *, p 0.05; **, p 0.01.
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primary antibodies were used: anti-GluR1 (1:1,500, Upstate,
Waltham, MA), anti-GluR2 (1:600, Chemicon International,
Temecula, CA), anti-GluR3 (1:200, Zymed Laboratories Inc.,
San Francisco, CA), anti-GluR4 (1:200, Chemicon Interna-
tional), anti-pGluR1 Ser-831 (1:1,000, Chemicon Interna-
tional or 1:1,500, Tocris, UK), anti-pGluR1 Ser-845 (1:1,000,
Chemicon International), anti-pGluR2 Ser-880 (1:1,000,
Chemicon International), anti-pTrk (1:1,000, Cell Signaling,
Beverly, MA), and anti-TrkB (clone 47, 1:1,000, BD Bio-
sciences). Anti--tubulin (1:1,000, Zymed Laboratories
Inc.), anti--tubulin I (1:150,000, Sigma), anti-actin
(1:20,000, Chemicon), and anti-transferrin receptor
(1:3,000, Zymed Laboratories Inc.) antibodies were used as
loading controls.
Electrophysiology—After 3–5 days in culture, the organo-
typic cultures of rat hippocampal slices, prepared as previously
described (25), were infected (36 h) with the Sindbis virus
expressing recombinant GluR1 or GluR1 plus the constitutive
active CaMKII (as indicated), tagged to GFP. Voltage clamp
whole cell recordings were obtained from infected and unin-
fected CA1 pyramidal neurons, under visual guidance using
fluorescence and transmitted light illumination. The recording
chamber was perfused with 119 mM NaCl, 2.5 mM KCl, 4 mM
CaCl2, 4 mM MgCl2, 26 mM NaHCO3, 1 mM NaH2PO4, 11 mM
glucose, 0.1 mM picrotoxin, 0.1 mM DL-2-amino-5-phosphono-
valeric acid (APV), and 2 M 2-chloroadenosine (pH 7.4),
gassed with 5% CO2/95% O2. Patch recording pipettes (4–7
M	) were filled with the 115 mM cesiummethanesulfonate, 20
mMCsCl, 10mMHEPES, 2.5mMMgCl2, 4mMNa2ATP, 0.4mM
Na3GTP, 10 mM sodium phosphocreatine, 0.6 mM EGTA, and
0.1mM spermine (pH 7.25).Whole cell recordings were carried
out with a MultiClamp 700A amplifier (Axon Instruments,
Union City, CA). Synaptic responses were evoked with two
bipolar electrodes with single voltage pulses (duration of
0.3ms, up to 20V). The stimulating electrodeswere placed over
Schaffer collateral fibers between 200 and 300 m from the
recorded cells. Synaptic AMPA receptor-mediated responses
were collected at 60 mV and 40 mV with glass electrodes
placed in CA1 stratum radiatum and averaged over 50–60 tri-
als; their ratio was used as an index of rectification. All electro-
physiological data were collected with pCLAMP software
(Axon Instruments). When the effect of K252a (200 nM) was
tested, the drug was added to the perfusion medium 30 min
prior to incubation with 100 ng/ml BDNF. Incubation with
BDNF was performed from 30 min to 2.5 h. When the effect of
NMDA receptor activity on AMPA delivery to the synapse was
studied, NMDA receptor-mediated responses were blocked
pharmacologically using 0.1 mM APV.
Statistical Analysis—Statistical analysis was performed using
one-way ANOVA followed by the Dunnett test or Bonferroni
test, or using the Student’s t test, as indicated in the figure
captions.
RESULTS
Effect of BDNF on the Total Protein Levels of AMPA Receptor
Subunits—To determine whether acute stimulation with
BDNF affects the abundance of glutamate receptor subunits, 7
DIV cultured hippocampal neurons were incubated with or
without 100 ng/ml BDNF, for various periods of time (15min to
24 h). The AMPA receptor subunit (GluR1, GluR2, GluR3, and
GluR4) protein levels were determined by Western blotting
(Fig. 1). BDNF rapidly up-regulated GluR1-GluR3 protein lev-
els, in a transient manner, with small effects observed already
after 15 min of stimulation with the neurotrophin (Fig. 1, A, C,
and E). In contrast, BDNF did not change GluR4 protein levels
(Fig. 1F). The increases in GluR1, GluR2, and GluR3 had dis-
tinct kinetics, and themaximal effectswere observed after incu-
bation with BDNF for 1 h, 2 h, and 30 min, respectively. For
longer periods of BDNF stimulation (12–24 h), the abundance
of GluR1-GluR3 subunits decreased to values similar to the
control. Because there was little GluR3 immunoreactivity with
the antibody used, the effect of BDNF on this subunit was not
further examined.
In contrast with the results obtained using 7 DIV hippocam-
pal neurons, BDNF did not affect GluR1 and GluR2 protein
levels in neurons cultured for 14 DIV, for incubation periods
with the neurotrophin of 2–24 h (Fig. 1, B and D). However,
when the endogenous extracellular BDNF was chelated with
the fusion protein TrkB-IgG for 24 h, the levels of GluR1 signif-
icantly decreased (Fig. 2A), whereas no changes were observed
for the GluR2 subunit (Fig. 2B). These results indicate that
endogenous BDNF regulates theGluR1 protein levels in 14DIV
cultures of hippocampal neurons. Activation of Trk neurotro-
phin receptors was required for up-regulation of GluR1 and
GluR2 AMPA receptor subunits by BDNF in 7 DIV cultures,
because no effect of the neurotrophin was observed when the
experiments were conducted in the presence of K252a (200
nM), an inhibitor of this family of receptors (Fig. 3).
To test whether the effect of BDNF was due to an increase in
protein synthesis, we used two translation inhibitors, emetine
and anisomycin. Hippocampal neurons were stimulated with
BDNF for 3 h, in the presence or in the absence of the transla-
tion inhibitors. Emetine (2 M) and anisomycin (2 M) abro-
gated the effect of BDNF onGluR1 andGluR2 subunits (Fig. 4).
None of the protein synthesis inhibitors reduced the GluR1 or
GluR2 protein levels under control conditions, in agreement
with the long half-life of AMPA receptor subunits (28–30).
FIGURE 2. Chelation of endogenous released BDNF with the fusion pro-
tein TrkB-IgG decreases the protein levels of GluR1 but was without
effect onGluR2protein levels. 14DIVneuronswere incubatedwith orwith-
out 1 g/ml TrkB-IgG for 24 h. Total GluR1 (A) and GluR2 (B) protein levels
were measured by Western blot. Control protein levels of AMPA receptor
subunitswere set to 100%.-Tubulinwas used as loading control. The results
are the average S.E. of 5–6 independent experiments, performed in inde-
pendentpreparations. Statistical analysiswasperformedbyone-wayANOVA,
followed by the Dunnett test. *, p 0.05.
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Taken together, our findings indicate that the effect of BDNF
on AMPA receptor subunits is mediated by activation of TrkB
receptor and is due to an up-regulation of protein synthesis
instead of a reduction in protein degradation.
BDNF Up-regulates AMPA Receptor Subunits by Promoting
Transcription Activity—BDNFmay stimulate either transcrip-
tion of genes (22) or stimulate protein synthesis by activat-
ing translation cascades (31). Therefore, to test for the role of
transcription in the up-regulation of glutamate receptor
subunits by BDNF we used two different transcription inhib-
itors, -amanitine (1.5 M) and actinomycin D (1.5 M).
Both transcription inhibitors blocked the effect of BDNF on
GluR1 and GluR2 protein levels, but were without effect on
the abundance of the receptor subunits in the absence of the
neurotrophin (Fig. 5). In agreement with these observations,
real-time PCR using the SYBR green assay showed that
BDNF stimulation for 30 min increased significantly the
mRNA levels for GluR1, and when the cells were incubated
with the neurotrophin for 3 h a significant increase in the
mRNA for GluR1 and GluR2 was also observed (Fig. 6).
Taken together, the results indicate that BDNF regulates
GluR1 and GluR2 AMPA receptor subunits at the transcrip-
tion level. In contrast with the results obtained for GluR1
and GluR2, no effect of BDNF was observed on the mRNA
levels for GluR3 and GluR4.
Effect of BDNF on GluR1 and GluR2 Protein Levels at the
PlasmaMembrane—Because a significant percentage of gluta-
mate receptors expressed in neurons is intracellular (32) and,
therefore, do not participate in the response to the neurotrans-
mitter glutamate, we testedwhether BDNF can affect the trans-
location of AMPA receptor subunits to the plasma membrane.
To study the effect of BDNF on the cell surface distribution of
the AMPA receptor subunits GluR1 andGluR2, 7 DIV cultured
FIGURE 3. Inhibition of Trk activity blocks the BDNF-induced up-regula-
tion of GluR1 and GluR2 protein levels. Neurons (7 DIV) were incubated
with or without 100 ng/ml BDNF for 2 h, in the presence or in the absence of
K252a (200 nM). When the inhibitor was present it was preincubated 30 min
before stimulation with BDNF. Total GluR1 and GluR2 protein levels were
measured by Western blot. Control (unstimulated) protein levels of AMPA
receptor subunits were set to 100%. Actin was used as loading control. The
results are theaverageS.E. of 7–18 independent experiments, performed in
independent preparations. Statistical analysis was performed by one-way
ANOVA, followed by the Bonferroni test. ***, p 0.001.
FIGURE 4. Translation inhibitors impair the BDNF-induced up-regulation
of GluR1 and GluR2 protein levels.Neurons (7 DIV) were incubated with or
without 100 ng/ml BDNF for 3 h, in the presence or in the absence of emetine
(2.0 M, left panels) or anisomycin (2.0 M, right panels). When the inhibitors
wereused the cellswerepreincubatedwith the compounds for 30minbefore
stimulation with BDNF. Total GluR1 (top panels) and GluR2 (bottom panels)
protein levels were measured by Western blot. Control (unstimulated) pro-
tein levels of AMPA receptor subunits were set to 100%. Actin was used as
loading control. The results are the average  S.E. of 6–12 independent
experiments, performed in independentpreparations. Statistical analysiswas
performed by one-way ANOVA, followed by the Bonferroni test. **, p 0.01;
***, p 0.001. DMSO, Me2SO.
FIGURE 5. Transcription inhibitors prevent the BDNF-induced up-regula-
tionof theGluR1andGluR2protein levels.Neurons (7DIV)were incubated
with or without 100 ng/ml BDNF for 3 h, in the presence or in the absence of
-amanitine (1.5M, left panels) or actinomycin D (1.5M, right panels). When
the inhibitorswere used the cellswere preincubatedwith the compounds for
30 min before stimulation with BDNF. Total GluR1 (top panels) and GluR2
(bottom panels) protein levels were measured by Western blot. Control
(unstimulated) protein levels of AMPA receptor subunits were set to 100%.
Actin was used as loading control. The results are the average S.E. of 5–10
independent experiments, performed in independent preparations. Statisti-
cal analysis was performed by one-way ANOVA, followed by the Bonferroni
test. *, p 0.05.
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hippocampal neurons were treated with or without 100 ng/ml
BDNF (30min, 3 h, and 24 h). Following treatment, proteins on
the cell surface were biotinylated, collected with streptavidin-
or NeutrAvidin-coupled beads, and subjected toWestern blot-
ting (Fig. 7). GluR1 protein associated with the plasma mem-
brane was markedly increased by BDNF treatment during 30
min when compared with non-treated cells. However, incuba-
tion with BDNF for 3 h was without effect (Fig. 7A). The
increase observed by BDNF treatment during 30 min was
blocked by emetine (Fig. 7B), indicating that the BDNF-in-
duced up-regulation in the amount of plasmamembrane-asso-
ciated GluR1 requires de novo protein synthesis. In contrast,
BDNFdid not affect significantly theGluR2 protein levels at the
plasma membrane (Fig. 7D). These results indicate that BDNF
has a differential effect on the traffic of AMPA receptor sub-
units in developing cultured hippocampal neurons. Also, the
distinct time courses for the increase in surface and total GluR1
expression suggest that the effects of BDNF on total GluR1
content and receptor trafficking may be mediated by separate
signaling pathways. In contrast with the results obtained in
developing neurons, BDNF did not affect the surface expres-
sion of GluR1 in 14 DIV cultured hippocampal neurons
(Fig. 7C).
The delivery of GluR1 subunits to the synapse is regulated by
phosphorylation in the C-terminal region. GluR1 is phospho-
rylated on Ser-831 during LTP, although this phosphorylation
is not sufficient to induce synaptic delivery of AMPA receptors
(24, 26, 33, 34). Stimulation of cultured hippocampal neurons
(7 DIV) with BDNF (100 ng/ml) increased the phosphorylation
of GluR1 on Ser-831, as determined by Western blot using a
phosphospecific antibody (Fig. 7E). However, because the total
amount of GluR1 present in the cells was also increased upon
stimulation with the neurotrophin, the percentage of total pro-
tein that was phosphorylated was not significantly changed
(Fig. 7F, see also Fig. 1A). To better understand which signaling
pathways may be involved in GluR1 phosphorylation following
Trk receptor activation, and because Ser-831 is a phosphoryla-
tion site for protein kinase C (PKC) and Ca2-calmodulin-de-
pendent protein kinase II (CaMKII) (24, 26), the effect of the
kinase inhibitors chelerythrine (5 M) and KN-93 (10 M) was
tested. Inhibition of PKC and CaMKII with chelerythrine and
KN-93, respectively, inhibited GluR1 phosphorylation on Ser-
831, suggesting that both pathways contribute to the effect of
BDNF (Fig. 7E).
Effect of BDNF on Synaptic Delivery of AMPAReceptors—We
next examined the role of BDNF in the trafficking of AMPA
receptors into the synapse, in CA1 neurons of rat hippocam-
pal organotypic slices expressing GluR1-GFP. Overexpres-
sion of GluR1-GFP, with a Sindbis virus expression system,
leads to the formation of homomeric AMPA receptors con-
taining the GluR1 subunit (33). These GluR2-lacking recep-
tors are inwardly rectifying (35–37), and therefore their
recruitment to the synapse increases the inward currents at
60 mV, with no effect on the outward currents. Hence,
synaptic delivery of GluR1-containing AMPA receptors to
the synapse can be monitored as an increase in the ratio
between the currents at 60 mV versus the currents at 40
mV (rectification index) (33). As expected, overexpression of
GluR1 in CA1 hippocampal neurons did not increase the
rectification index of synaptic responses (Fig. 8, A and B;
compare first and second columns in Fig. 8B), confirming
that GluR1 is not spontaneously delivered into synapses (33).
In marked contrast, the rectification index of homomeric
GluR1-expressing neurons was significantly increased upon
incubation with BDNF (100 ng/ml) for 30 min to 3 h (Figs. 7B
and 8A; compare second and fourth columns in Fig. 8B).
BDNF had no significant effect on the rectification index of
non-infected cells (Fig. 8B; compare first and third columns).
The effect of BDNF was similar to that observed in cells
where GluR1 was coexpressed with a constitutively active
form of CaMKII (tCaMKII, Fig. 7B and 8A; compare fourth
and seventh columns in Fig. 8B), which is known to induce
synaptic delivery of GluR1-containing AMPA receptors (33,
38). Inhibition of the Trk receptors with K252a (200 nM)
completely prevented synaptic delivery of AMPA receptors
induced by BDNF (Fig. 8B; compare fourth and fifth col-
umns). Taken together, the results indicate that BDNF
induces a very efficient delivery of GluR1 homomeric recep-
tors into synapse and that this effect is mediated by binding
of BDNF to Trk receptors.
Tetanic stimulation was shown to induce a rapid delivery of
GFP-GluR1-containing AMPA receptors into dendritic spines
and cause receptor clustering in dendrites by a mechanism
requiring activation of NMDA receptors (39). To determine
whether synaptic delivery of GFP-GluR1-containing AMPA
receptors induced by BDNF requires activation of NMDA
receptors, experiments were performed in the presence of the
NMDA receptor antagonist APV. Preincubation of the slices
with APV (100 M) for 30 min did not affect the increase in the
rectification index induced by BDNF (Fig. 8B; compare fourth
and sixth columns).
Stimulation of hippocampal slices with BDNF (100 ng/ml)
for 30-min increasedGluR1phosphorylation on Ser-831 (Fig. 9,
A and B), in agreement with the results obtained in monolayer
cultures of hippocampal neurons (Fig. 7E). In contrast, no
FIGURE 6.BDNF increases themRNA levels of theGluR1 andGluR2AMPA
receptor subunits. The variation of GluR1 and GluR2 mRNA levels was
assayed by SYBR Green real-time PCR of total RNA samples, converted to
cDNA in reactions normalized to contain equal amounts ofmRNA. The cells (7
DIV)were incubated in thepresenceor absenceof 100ng/mlBDNF, during30
min (gray columns) or 3 h (black columns). The results are presented as mean
percentage S.E. comparedwith the control (unstimulated), andnormalized
to the reference gene 18 S, and are the average  S.E. of 3–7 independent
experiments, performed in independentpreparations. Statistical analysiswas
performed by one-way ANOVA, followed by the Dunnett test. *, p  0.05;
***, p 0.001.
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change in GluR1 phosphorylation was detected for Ser-845
(Fig. 9A). The activation of Trk receptors by BDNF was con-
firmed by Western blot, using an antibody that recognizes
phosphotyrosine 490 in TrkA, a residue conserved in the other
Trk receptors. Stimulation of hippocampal slices with BDNF
for 30min significantly increased Trk (presumably TrkB) phos-
phorylation. Control experiments
showed that the total GluR1 and
Trk protein levels did not change
significantly in the slices under the
experimental conditions used (Fig.
9A). The effect of BDNF on GluR1
phosphorylation was specific,
because no phosphorylation of
GluR2 on the PKC phosphorylation
site (Ser-880 (24)) was observed
(Fig. 9A).
DISCUSSION
It is well known that BDNF plays
an important role in synaptic plas-
ticity (1, 40, 41), particularly in LTP
induced by high frequency stimula-
tion (42–44), which in late phase
requires transcription activation
and protein synthesis (45). Accord-
ingly, LTP is impaired in the hip-
pocampal CA3-CA1 region of bdnf
null mutant and forebrain-specific
trkB knock-outmice (3, 4, 46, 47). In
the latter case, a compromised
learning ability was also shown (46).
However, the mechanisms whereby
BDNF contributes to LTP are not
fully understood. In this study, we
show that Trk receptor activation
(presumably TrkB) by BDNF rap-
idly up-regulates GluR1 and GluR2
protein levels in cultured hip-
pocampal neurons, by increasing
transcription activity. Although
BDNF also up-regulatedGluR3 pro-
tein levels, no effect on the mRNA
for this receptor subunit was
observed. The neurotrophin also
induced phosphorylation of GluR1
on Ser-831, most likely by activating
PKC and CaMKII, and promoted
synaptic delivery of GluR1-contain-
ing AMPA receptors in the CA1
region of the hippocampus.
Short incubation periods with
BDNF (30min) up-regulated GluR1
and GluR2 protein levels to about
the same extent in cultured hip-
pocampal neurons (Fig. 1, A and C)
but selectively increased the
amount of GluR1 subunits associ-
ated with the plasma membrane (Fig. 7). These findings indi-
cate that the delivery of GluR1 andGluR2 subunits to themem-
brane is differentially regulated, as shown for synaptic delivery
of the AMPA receptor subunits in the adult hippocampus (48,
49). Furthermore, we found that the BDNF acutely increases
GluR1 subunit associated with the plasma membrane by
FIGURE 7. BDNF increases the GluR1 subunit in the plasma membrane, but not the GluR2 subunit, in
developing cultured hippocampal neurons. 7 DIV (A, B, and D) or 14 DIV (C) cultured neurons were treated
with or without 100 ng/ml BDNF (30 min, 3 h, and 24 h) as indicated. In panel B, 7 DIV neurons were preincu-
bated or not with emetine (2.0M), for 30min, before stimulation with BDNF, for 30min, in the presence or in
the absence of the inhibitor. Following treatment, cell surface proteinswere labeled by biotinylation, followed
by precipitation with streptavidin beads. The abundance of each subunit in the plasma membrane was then
determined by Western blot. Control (unstimulated) levels of AMPA subunits protein was set to 100%. The
transferrin receptor was used as loading control. The effect of BDNF on GluR1 phosphorylation on Ser-831
(pGuR1 Ser-831) is shown in panel E. 7 DIV cultured hippocampal neurons were incubated for 30 min with or
without BDNF, in the presence or absence of chelerythrine (5 M) or KN-93 (10 M). The phosphorylation of
GluR1 on Ser-831 was measured by Western blot, using a phosphospecific antibody. Control (unstimulated)
phosphorylation of GluR1 was set to 100%. -Tubulin was used as loading control. The total amount of GluR1
was determined after striping themembranes, and the ratio between pGluR1 Ser-831 and the total amount of
GluR1 is plotted in panel F. The results are the average S.E. of 3–13 independent experiments, as indicated,
performed in independent preparations. Statistical analysis was performed by one-way ANOVA, followed by
the Dunnett test (A, C, and D) or Bonferroni test (B and E). **, p 0.01.
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enhancing the translation activity (Fig. 7B). This may be due to
the delivery of newly synthesized receptors to the plasmamem-
brane and/or to an increased stability of the plasmamembrane-
associated receptors by interaction with protein(s) synthesized
following Trk receptor stimulation. The acute effects of BDNF
on the plasma membrane GluR1 protein levels may require
continuous signaling activity by Trk receptors, because after
3-h stimulation with BDNF, when Trk receptors are desensi-
tized to some extent (50), the receptor subunits found in the
membrane were similar to the control. In contrast with the
results obtained in 7 DIV cultures, when synaptogenesis is par-
ticularly active (51), addition of BDNF had no effect on GluR1
and GluR2 protein levels in hippocampal neurons cultured for
14 DIV (Fig. 1, B and D). In these cultures, chelation of endog-
enous extracellular BDNF with the fusion protein chimera
TrkB-IgG selectively decreased the GluR1 levels, indicating
that BDNF has a tonic effect on GluR1 protein levels (Fig. 2).
These results suggest that the lack of effect of BDNF on total
GluR1 protein levels in 14 DIV hippocampal cultures (Fig. 1B),
and on the total amount of surface receptors (Fig. 7C), may be
due to the activity of endogenous BDNF, which controls to
some extent the abundance of GluR1, thereby precluding an
effect of exogenous addition of the neurotrophin. Thismay also
explain the results showing no effect of BDNF on total GluR1
protein levels in the organotypic slices (Fig. 9A).
Electrophysiology studies have also shown that BDNF
induces synaptic delivery of GluR1-containing AMPA recep-
tors in CA1 neurons of hippocampal organotypic slices
expressing GluR1-GFP, by a mechanism independent of
NMDA receptor activity (Fig. 8B). This contrasts with the role
of NMDA receptors in synaptic delivery of GluR1-containing
AMPA receptors following tetanic stimulation (39). The synap-
tic delivery of GluR1 induced by BDNFwas sensitive to the Trk
inhibitor K252a andwas associatedwith the phosphorylation of
the protein in Ser-831, the CaMKII and PKC phosphorylation
site (24). Interestingly, GluR1 phosphorylation in Ser-831 was
also observed upon induction of LTP in naı¨ve synapses (34). In
contrast, BDNF did not affect GluR1 phosphorylation in Ser-
845, which is preferentially phosphorylated upon high fre-
quency stimulation of previously depressed synapses (34).
Because GluR1 phosphorylation in Ser-831 is not sufficient to
induce synaptic delivery of AMPA receptors (33), the effect of
BDNF may also involve GluR1 phosphorylation on Ser-818.
Phosphorylation of this site is significantly increased during
hippocampal LTP, playing an important role in synaptic incor-
poration of GluR1 (52). Alternatively, BDNF may induce the
phosphorylation of a regulatory protein, leading to the release
of a retention interaction and allowing the incorporation of
GluR1 subunits into the synapse. Phosphorylation of GluR1 on
Ser-831 may also allow the interaction with a protein that
anchors the receptor at the plasma membrane.
The effect of BDNFon synaptic delivery of GluR1was similar
to that observed in cells where a constitutively active form of
CaMKII was coexpressed, suggesting that analogous signaling
mechanisms may be involved. In fact, treatment of cultured
hippocampal neurons also increased the phosphorylation of
GluR1 on Ser-831, and this effect was abolished by inhibition of
PKC and CaMKII, suggesting that both pathways are involved
in the BDNF-induced GluR1 phosphorylation and possibly on
the delivery of AMPA receptors to the synapse. In agreement
with the role of PKC and CaMKII in BDNF-induced GluR1
phosphorylation, activation of TrkB receptors stimulates the
phospholipase C pathway, giving rise to diacylglycerol, which
activates PKC, and inositol-1,4,5-trisphosphate, which mobi-
lizes Ca2 from intracellular stores (10, 11). Interestingly, this
signaling pathway is involved in the synaptic changes resulting
from local application of BDNF to the Xenopus laevis optic
tectum, which cause rapid modifications of synaptic inputs at
FIGURE 8. BDNF increases the delivery of the AMPA receptors to the syn-
apse. AMPA receptor-mediated responses were recorded at 60 mV and
40 mV from CA1 neurons, and the rectification index was calculated as the
ratio between the responses at these holding potentials (I60 mV/I40 mV).
A, AMPA receptor-mediated responses at 60 mV and 40 mV in neurons
infected with Sindbis virus expressing recombinant GluR1 or GluR1 plus the
constitutive active CaMKII tagged to GFP. GluR1-infected cells were incu-
bated (gray line) or not (black line)with 100ng/ml BDNF.B, rectification values
were obtained from uninfected neurons, and from neurons infected with
recombinant GluR1 or GluR1 plus the constitutive active CaMKII (as indi-
cated), tagged to GFP. Where indicated the cells were stimulated with 100
ng/ml BDNF for 30min to 3 h. Because no difference was found between the
results obtained for the various preincubation periods tested, the results
were pooled together. The effect of 200 nM K252a and 0.1 mM APV on the
BDNF-induced increase on the rectification index was also tested by perfus-
ing the hippocampal slices with these compounds for 30 min prior to BDNF
incubation and during the recordings. The results are the average  S.E. of
the indicated number of experiments. Statistical analysis was performed
using the Student t test. **, p 0.01; ***, p 0.001.
FIGURE 9. BDNF induces the phosphorylation of GluR1 on Ser 831. A, hip-
pocampal slices were stimulated with 100 ng/ml BDNF for 30 min, and Trk,
GluR1, andGluR2phosphorylationwas analyzedbyWesternblot, usingphos-
phospecific antibodies. BDNF induces phosphorylation of Trk receptor, and
GluR1 phosphorylation at Ser-831 but not at Ser-845. GluR2 phosphorylation
at Ser-880 is not affected by BDNF (A and B). The phosphorylation of GluR1 on
Ser-831 and the phosphorylation of Trk were normalized to GluR1 and Trk
receptor protein levels, respectively. The results are the average S.E. of 3–4
independent experiments. Statistical analysis was performed using the Stu-
dent t test. *, p 0.05; ***, p 0.001.
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the dendrites of retinal ganglion cells by up-regulating AMPA
receptors at the retinal ganglion cells (53). Furthermore,
recruitment of phospholipase C by active TrkB receptors was
shown to play a role in hippocampal LTP (54).
Although activation of NMDA receptors induces a rapid
delivery of GluR1-containing AMPA receptors to the synapse,
and their clustering in dendrites (39), this does not account for
the effect of BDNF, because we found no effect of the NMDA
receptor antagonist APV on BDNF-induced delivery of GluR1
subunits to the synapse. Interestingly, inhibition of NMDA
receptors was also shown not to affect BDNF-induced LTP at
medial perforant path to granule cell synapses in the rat dentate
gyrus, in contrast with the high frequency stimulation-induced
LTP, which depends on the activation ofNMDA receptors (22).
In addition to the rapid effects on delivery of GluR1 subunits
to the synapse in hippocampal CA1 neurons, and to the plasma
membrane in developing cultured hippocampal neurons,
BDNF also rapidly up-regulated GluR1, GluR2, and GluR3 pro-
tein levels in the latter preparation. This effect was transient,
most likely due to the desensitization of the Trk receptors, fol-
lowed by a decrease in intracellular signaling activity (50, 55).
The up-regulation in AMPA receptor subunits induced by
BDNF was due to an increase in transcription activity, as dem-
onstrated by the effect of transcription inhibitors, followed by
synthesis of the receptor subunits. The role of transcription
activity on the effect of BDNF on the protein levels of theGluR1
and GluR2 subunits is not surprising, because BDNF is known
to regulate transcription of several genes (44, 56) and to mod-
ulate transcription during the late phase LTP (22). In agree-
ment with the present findings, chronic treatment of cultured
cerebrocortical neurons with BDNF also increased GluR1 and
GluR2/3 protein levels, but no effect on the mRNA for the
receptor subunits was found under these conditions (57, 58).
However, in this case, the sustained stimulation of neurotro-
phin receptors from early in development may have caused
changes in cell phenotype.
The signaling mechanisms involved in the rapid increase in
the transcription of GluR1 and GluR2 in hippocampal neurons
exposed to BDNF remain to be identified. Previous studies have
shownGluR1 protein levelsmay be regulated by the serum- and
glucocorticoid-inducible kinase 3, one of the downstream tar-
gets of phosphatidylinositol 3-kinase (59), and by the tyrosine
kinase Fyn, which also regulates GluR2/3 (9). Studies in a het-
erologous system showed that the expression of GluR2 can be
regulated by BDNF, through a mechanism involving a neuron-
restrictive silencer element present within the GluR2 promoter
(60). These results are in agreement with our own results and
contrast with the effects observed in cerebrocortical neurons
chronically exposed to BDNF, where no change in the mRNA
for GluR2 was observed (57).
In addition to the effect of BDNF on the mRNA levels for
GluR1 andGluR2, which accounted for the up-regulation in the
AMPA receptor subunits in cultured hippocampal neurons, a
recent study showed that BDNF also increased GluR1 protein
levels in synaptoneurosomes (61). This effect, mediated by a
mammaliantargetof rapamycin-phosphatidylinositol3-kinase-
dependent pathway, may contribute to increase locally the
amount GluR1 after high frequency stimulation. Delivery of
these receptors to the synapse may contribute to LTP. Chronic
stimulation of neocortical neuronal cultures with BDNF also
increased the abundance of the AMPA receptor-interacting
proteins SAP97, GRIP1, and PICK1 (62). Under the same con-
ditions there was an increase in the interaction between GluR1
and SAP97, as well as between GluR2 and GRIP1, which was
suggested to play a role in the up-regulation ofAMPA receptors
by BDNF (62). It remains to be determined whether BDNF
induces a local synthesis and increase in the protein levels of
theseAMPAreceptor-interacting proteins, whichmay contrib-
ute to stabilize the receptors at the synapse.
In conclusion, our results strongly suggest that BDNF plays a
direct role in the early phase of synaptic plasticity by triggering
the delivery of GluR1 subunits to the synapse. Furthermore,
BDNF rapidly up-regulated AMPA receptor subunits in devel-
oping hippocampal neurons and induced an overall increase in
the number of receptors associated with the membrane during
a period of active synaptogenesis.
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PAGE 12619:
In the abstract, beginning with the third sentence, lines 6–13 should
read: “Here we show that BDNF acutely up-regulates GluR1, GluR2,
and GluR3 -amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
(AMPA) receptor subunits in 7-day in vitro cultured hippocampal neu-
rons. The increase in GluR1 and GluR2 protein levels in developing
cultures was impaired by K252a, a tropomyosin-related kinase (Trk)
inhibitor, and by translation (emetine and anisomycin) and transcrip-
tion (-amanitine and actinomycin D) inhibitors.”
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PAGE 55111:
In Table I, the first two lines of the legend should read: “Dextran 
BSA represents amixed crowding agent containing 90 g/liter dextran 70
and 10 g/liter BSA. Ficoll  BSA represents a mixed crowding agent
containing 90 g/liter Ficoll and 10 g/liter BSA.”
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